In a pioneering move, Beilinson Hospital has successfully completed a pilot program using iCAD’s Artificial Intelligence (AI) technologies to analyze over 15,000 mammography scans. The hospital announced the successful completion of the program on Monday. The technology was able to detect tumors that were previously undetected, significantly improving diagnostic capabilities and potentially saving lives by providing early detection of breast cancer in women over 40 years old.
One of the technology’s features is its ability to assess a patient’s risk level of developing a cancerous tumor in the next two years by scanning past dense tissue. Since the completion of the pilot earlier this year, the system has been implemented across the Clalit Health Services network, including its mammography units in hospitals and clinics nationwide. iCAD’s program has already received approval from the FDA in the United States.
Dr. Ahuva Grubstein, Head of Beilinson’s Mammography Department, emphasized the importance of early detection and intervention in treating breast cancer. She encouraged women and those at risk of cancer to undergo regular semi-annual mammography exams. By utilizing AI tools to assist radiologists in these scans, the reliability of the scans can be increased, leading to more cases of early detection and potentially saving lives.
The implementation of iCAD’s AI technologies has shown promising results in improving the accuracy and effectiveness of breast cancer detection since the start of the pilot program at Beilinson Hospital. The technology has been used to support radiologists in analyzing over 15,000 scans at Beilinson Hospital, leading to significant improvements in diagnostic capabilities.
